Antimicrobial Resistance and Therapy in Intensive Care Unit
This Reprint brings together cutting-edge contributions that address the acute and evolving challenge of antimicrobial resistance in the intensive care setting. Critically ill patients in Intensive Care Units (ICUs) face a disproportionate burden of infections caused by multidrug-resistant organisms...
Đã lưu trong:
| Định dạng: | Online |
|---|---|
| Ngôn ngữ: | Tiếng Anh |
| Được phát hành: |
MDPI - Multidisciplinary Digital Publishing Institute
2026
|
| Những chủ đề: | |
| Truy cập trực tuyến: | ONIX_20260416T142754_9783725863105_7 |
| Các nhãn: |
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| _version_ | 1869531406064943104 |
|---|---|
| collection | Directory of Open Access Books |
| description | This Reprint brings together cutting-edge contributions that address the acute and evolving challenge of antimicrobial resistance in the intensive care setting. Critically ill patients in Intensive Care Units (ICUs) face a disproportionate burden of infections caused by multidrug-resistant organisms, demanding a rigorous appraisal of both epidemiological trends and therapeutic strategies. In this collection we highlight three interconnected domains: (1) the dynamic epidemiology of key pathogens in ICUs, including Gram-negative bacilli, non-fermenters, and other high-risk bacteria; (2) advances in microbiological diagnostics—encompassing rapid molecular methods, phenotypic detection, and real-time therapeutic guidance techniques; and (3) optimization of antimicrobial therapy grounded in pharmacokinetics/pharmacodynamics, novel agents, and stewardship frameworks tailored to the critical-care environment. The aim is to offer clinicians, microbiologists, and researchers a coherent resource that merges mechanistic insights with practical treatment algorithms for complex resistance mechanisms. By integrating surveillance data, therapeutic case series, and reviews of emerging antimicrobials, this Reprint supports evidence-based decision-making and fosters interdisciplinary collaboration in the fight against antimicrobial resistance in intensive care. |
| format | Online |
| id | doab-20.500.12854ir-175202 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1752022026-04-16T19:33:46Z Antimicrobial Resistance and Therapy in Intensive Care Unit Vidal-Cortés, Pablo Suberviola-Cañas, Borja Andaluz-Ojeda, David Intensive Care Unit Multidrug-resistant bacteria 2 Empirical antimicrobial therapy TDM Pseudomonas aeruginosa Cefiderocol Acinetobacter baumanii Stenotrophomonas maltophilia thema EDItEUR::M Medicine and Nursing This Reprint brings together cutting-edge contributions that address the acute and evolving challenge of antimicrobial resistance in the intensive care setting. Critically ill patients in Intensive Care Units (ICUs) face a disproportionate burden of infections caused by multidrug-resistant organisms, demanding a rigorous appraisal of both epidemiological trends and therapeutic strategies. In this collection we highlight three interconnected domains: (1) the dynamic epidemiology of key pathogens in ICUs, including Gram-negative bacilli, non-fermenters, and other high-risk bacteria; (2) advances in microbiological diagnostics—encompassing rapid molecular methods, phenotypic detection, and real-time therapeutic guidance techniques; and (3) optimization of antimicrobial therapy grounded in pharmacokinetics/pharmacodynamics, novel agents, and stewardship frameworks tailored to the critical-care environment. The aim is to offer clinicians, microbiologists, and researchers a coherent resource that merges mechanistic insights with practical treatment algorithms for complex resistance mechanisms. By integrating surveillance data, therapeutic case series, and reviews of emerging antimicrobials, this Reprint supports evidence-based decision-making and fosters interdisciplinary collaboration in the fight against antimicrobial resistance in intensive care. 2026-04-16T19:33:37Z 2026-04-16T19:33:37Z 2026 book ONIX_20260416T142754_9783725863105_7 9783725863105 9783725863112 https://directory.doabooks.org/handle/20.500.12854/175202 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/ https://mdpi.com/books/pdfview/book/12114 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-6311-2 10.3390/books978-3-7258-6311-2 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725863105 9783725863112 178 CH open access |
| spellingShingle | Intensive Care Unit Multidrug-resistant bacteria 2 Empirical antimicrobial therapy TDM Pseudomonas aeruginosa Cefiderocol Acinetobacter baumanii Stenotrophomonas maltophilia thema EDItEUR::M Medicine and Nursing Antimicrobial Resistance and Therapy in Intensive Care Unit |
| title | Antimicrobial Resistance and Therapy in Intensive Care Unit |
| title_full | Antimicrobial Resistance and Therapy in Intensive Care Unit |
| title_fullStr | Antimicrobial Resistance and Therapy in Intensive Care Unit |
| title_full_unstemmed | Antimicrobial Resistance and Therapy in Intensive Care Unit |
| title_short | Antimicrobial Resistance and Therapy in Intensive Care Unit |
| title_sort | antimicrobial resistance and therapy in intensive care unit |
| topic | Intensive Care Unit Multidrug-resistant bacteria 2 Empirical antimicrobial therapy TDM Pseudomonas aeruginosa Cefiderocol Acinetobacter baumanii Stenotrophomonas maltophilia thema EDItEUR::M Medicine and Nursing |
| topic_facet | Intensive Care Unit Multidrug-resistant bacteria 2 Empirical antimicrobial therapy TDM Pseudomonas aeruginosa Cefiderocol Acinetobacter baumanii Stenotrophomonas maltophilia thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20260416T142754_9783725863105_7 |